Three-arm randomized study of two cisplatin-based regimens and paclitaxel plus gemcitabine in advanced non-small-cell lung cancer: A phase III trial of the European Organization for Research and Treatment of Cancer Lung Cancer Group - EORTC 08975
- Author
- EF SMIT, Jan Van Meerbeeck (UGent) , P LIANES, C DEBRUYNE, C LEGRAND, F SCHRAMEL, H SMIT, R GAAFAR, B BIESMA, C MANEGOLD, N NEYMARK and G GIACCONE
- Organization
Downloads
-
3909.pdf
- full text
- |
- open access
- |
- |
- 193.22 KB
Citation
Please use this url to cite or link to this publication: http://hdl.handle.net/1854/LU-208659
- MLA
- SMIT, EF, et al. “Three-Arm Randomized Study of Two Cisplatin-Based Regimens and Paclitaxel plus Gemcitabine in Advanced Non-Small-Cell Lung Cancer: A Phase III Trial of the European Organization for Research and Treatment of Cancer Lung Cancer Group - EORTC 08975.” JOURNAL OF CLINICAL ONCOLOGY, vol. 21, no. 21, 2003, pp. 3909–17, doi:1854/2151.
- APA
- SMIT, E., Van Meerbeeck, J., LIANES, P., DEBRUYNE, C., LEGRAND, C., SCHRAMEL, F., … GIACCONE, G. (2003). Three-arm randomized study of two cisplatin-based regimens and paclitaxel plus gemcitabine in advanced non-small-cell lung cancer: A phase III trial of the European Organization for Research and Treatment of Cancer Lung Cancer Group - EORTC 08975. JOURNAL OF CLINICAL ONCOLOGY, 21(21), 3909–3917. https://doi.org/1854/2151
- Chicago author-date
- SMIT, EF, Jan Van Meerbeeck, P LIANES, C DEBRUYNE, C LEGRAND, F SCHRAMEL, H SMIT, et al. 2003. “Three-Arm Randomized Study of Two Cisplatin-Based Regimens and Paclitaxel plus Gemcitabine in Advanced Non-Small-Cell Lung Cancer: A Phase III Trial of the European Organization for Research and Treatment of Cancer Lung Cancer Group - EORTC 08975.” JOURNAL OF CLINICAL ONCOLOGY 21 (21): 3909–17. https://doi.org/1854/2151.
- Chicago author-date (all authors)
- SMIT, EF, Jan Van Meerbeeck, P LIANES, C DEBRUYNE, C LEGRAND, F SCHRAMEL, H SMIT, R GAAFAR, B BIESMA, C MANEGOLD, N NEYMARK, and G GIACCONE. 2003. “Three-Arm Randomized Study of Two Cisplatin-Based Regimens and Paclitaxel plus Gemcitabine in Advanced Non-Small-Cell Lung Cancer: A Phase III Trial of the European Organization for Research and Treatment of Cancer Lung Cancer Group - EORTC 08975.” JOURNAL OF CLINICAL ONCOLOGY 21 (21): 3909–3917. doi:1854/2151.
- Vancouver
- 1.SMIT E, Van Meerbeeck J, LIANES P, DEBRUYNE C, LEGRAND C, SCHRAMEL F, et al. Three-arm randomized study of two cisplatin-based regimens and paclitaxel plus gemcitabine in advanced non-small-cell lung cancer: A phase III trial of the European Organization for Research and Treatment of Cancer Lung Cancer Group - EORTC 08975. JOURNAL OF CLINICAL ONCOLOGY. 2003;21(21):3909–17.
- IEEE
- [1]E. SMIT et al., “Three-arm randomized study of two cisplatin-based regimens and paclitaxel plus gemcitabine in advanced non-small-cell lung cancer: A phase III trial of the European Organization for Research and Treatment of Cancer Lung Cancer Group - EORTC 08975,” JOURNAL OF CLINICAL ONCOLOGY, vol. 21, no. 21, pp. 3909–3917, 2003.
@article{208659, author = {{SMIT, EF and Van Meerbeeck, Jan and LIANES, P and DEBRUYNE, C and LEGRAND, C and SCHRAMEL, F and SMIT, H and GAAFAR, R and BIESMA, B and MANEGOLD, C and NEYMARK, N and GIACCONE, G}}, issn = {{0732-183X}}, journal = {{JOURNAL OF CLINICAL ONCOLOGY}}, language = {{eng}}, number = {{21}}, pages = {{3909--3917}}, title = {{Three-arm randomized study of two cisplatin-based regimens and paclitaxel plus gemcitabine in advanced non-small-cell lung cancer: A phase III trial of the European Organization for Research and Treatment of Cancer Lung Cancer Group - EORTC 08975}}, url = {{http://doi.org/1854/2151}}, volume = {{21}}, year = {{2003}}, }
- Altmetric
- View in Altmetric
- Web of Science
- Times cited: